LXEO
Lexeo Therapeutics·NASDAQ
--
--(--)
--
--(--)
LXEO fundamentals
Lexeo Therapeutics (LXEO) released its earnings on Aug 14, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.6 (YoY +6.25%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.6
+6.25%
Report date
Aug 14, 2025
Earnings Call
9:30 AM on Aug 11, 2025
Meeting link.EPS
Actual | -0.86 | -0.64 | -0.89 | -0.78 | -0.99 | -0.6 |
Forecast | -0.6967 | -0.6914 | -0.6784 | -0.8071 | -0.7833 | -0.6794 |
Surprise | -23.44% | +7.43% | -31.19% | +3.36% | -26.39% | +11.69% |
Revenue
Actual | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is Lexeo Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Lexeo Therapeutics’s earnings call?What were the key takeaways from Lexeo Therapeutics's earnings call?What is Lexeo Therapeutics's gross profit margin?What is the revenue and EPS growth rate for Lexeo Therapeutics year over year?What is the market's earnings forecast for Lexeo Therapeutics next quarter?What does Lexeo Therapeutics do and what are its main business segments?Did Lexeo Therapeutics beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
